一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Peramivir
Peramivir
  • Peramivir

Peramivir NEW

Price $30 $64 $106
Package 1mg 5mg 10mg
Supply Ability: 10g
Update Time: 2026-05-26

Product Details

Product Name: Peramivir CAS No.: 330600-85-6
Purity: 99.90% Supply Ability: 10g
Release date: 2026/05/26

Product Introduction

Bioactivity

NamePeramivir
DescriptionPeramivir (BCX1812) is a highly selective influenza A and B neuraminidase inhibitor with antiviral activity and anti-cytokine effects, which can be used in the study of novel coronavirus and influenza virus infections.
In vitroPeramivir (2-10 μM, 6-12 h) inhibits LPS-induced cytokine release from hPBMCs[4]. Peramivir (0.3125-40 μM, 4 h) is non-toxic to macrophages[4].
In vivoPeramivir (20-60 mg/kg, intraperitoneal injection, single dose) inhibits LPS-induced cytokine storm, attenuates acute lung injury, and prolongs survival in a mouse model of cytokine storm syndrome [4]. Peramivir (75 mg/kg, intramuscular injection once daily for 7 days) rescued BR/08 lethally attacked BALB scid mice in an immunosuppressed mouse model of influenza B virus infection [5].
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility InformationDMSO : < 1 mg/mL (insoluble)
KeywordsRWJ-270201 | Peramivir | BCX-1812 | Antiviral | 229614-55-5
Inhibitors RelatedUndecane | Flubendazole | Esculin | Urea | Bisphenol A | Gum arabic | Hexane-2,5-dione | Fumaric acid | Lactose | Sodium formate | D-Psicose | Gluconate Calcium
Related Compound LibrariesFailed Clinical Trials Compound Library | Bioactive Compound Library | EMA Approved Drug Library | Kinase Inhibitor Library | Anti-Viral Compound Library | Drug Repurposing Compound Library | Inhibitor Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
VIP7Y
Shaanxi Dideu Medichem Co. Ltd
2025-12-24
VIP2Y
Shaanxi Dideu New Materials Co. Ltd
2025-12-01
PNP Biotech Co. Ltd
2024-03-28
$200.00
Hebei Mingeng Biotechnology Co., Ltd
2023-06-26
$1.00
VIP8Y
Career Henan Chemical Co
2019-07-06

TargetMol Chemicals Inc.

6YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY
乌恰县| 常熟市| 镇江市| 城口县| 广饶县| 公主岭市| 浑源县| 湄潭县| 龙南县| 承德县| 深水埗区| 岐山县| 枣庄市| 武鸣县| 如东县| 肇州县| 宜章县| 吐鲁番市| 勃利县| 南漳县| 尖扎县| 宝山区| 冷水江市| 刚察县| 山西省| 习水县| 汉寿县| 满洲里市| 丰原市| 福海县| 南开区| 凤冈县| 富裕县| 通城县| 邵阳县| 利辛县| 册亨县| 进贤县| 柳江县| 绵竹市| 措勤县|